Product Specification
| Alternative Name: | p55, CD120a, TNF-R 60kDa, TNFRSF 1A |
| |
| Concentration: | 1mg/ml after reconstitution. |
| |
| Endotoxin Content: | <0.1EU/µg purified protein (LAL test; Bio Whittaker). |
| |
| MW: | ~60kDa (reducing SDS-PAGE). |
| |
| Purity: | ≥95% (SDS-PAGE) |
| |
| Formulation: | Lyophilized. Contains PBS. |
| |
| Biological Activity: | Binds to TNF-R1 and triggers various biological effects (including cell death). rhTNF-R1:Fc fusion protein blocks TNF-α-mediated lysis with a inhibitory activity in a concentration range of 10-50ng/ml. |
| |
| Source/Host: | Produced in HEK 293 cells. The extracellular domain of human TNF-R1 (aa 1-211) is fused to the Fc portion of human IgG1. |
| |
| Reconstitution: | Reconstitute with 50µl sterile water. Further dilutions should be made with medium containing 5% fetal calf serum or carrier protein. |
| |
| Specificity: | Binds human and mouse TNF-α (tumor necrosis factor-a). |
| |
| Long Term Storage: | -20°C |
| |
| Use/Stability: | Stable for at least 6 months after receipt when stored at -20°C. |
| |
| Handling: | After reconstitution, prepare aliquots and store at -20°C. Avoid freeze/thaw cycles. |
| |
| Background / Technical Information: | UniProt ID P19438: TNF-R1 (human) |
| |
Figure: Inhibition of TNF-mediated lysis of WEHI 164 target cells (rhsTNF-a, Prod. No.
ALX-522-008). rhTNF-R1:Fc exerts its inhibitory activity in a concentration range of 10-50ng/ml.
Please mouse over
Product Literature References
Development of improved soluble inhibitors of FasL and CD40L based on oligomerized receptors: N. Holler, et al.; J. Immunol. Methods
237, 159 (2000),
Abstract;
The lymphotoxin-β receptor is necessary and sufficient for LIGHT-mediated apoptosis of tumor cells: I.A. Rooney, et al.; J. Biol. Chem.
275, 13047 (2000),
Abstract;
Full Text